RHYTHM PHARMACEUTICALS, INC. (69) | Business Finance (8)
Browse by Subcategory
Recent Contracts
-
Share Purchase Agreement, by and between Rhythm Pharmaceuticals Netherlands B.V. and Xinvento B.V., dated February 27, 2023
(Filed With SEC on March 1, 2023)
-
Underwriting Agreement, dated as of September 14, 2022, between Rhythm Pharmaceuticals, Inc. and Cowen and Company, LLC, Stifel, Nicolaus & Company, Incorporated and Wells Fargo...
(Filed With SEC on September 15, 2022)
-
2022 Employment Inducement Plan Form of Restricted Stock Unit Agreement
(Filed With SEC on March 1, 2022)
-
Amendment No. 1 to Amended and Restated Investors Rights Agreement, dated January 25, 2021
(Filed With SEC on November 2, 2021)
-
Underwriting Agreement, dated as of February 4, 2021, between Rhythm Pharmaceuticals, Inc. and Morgan Stanley & Co. LLC, BofA Securities, Inc., Cowen and Company, LLC and Stifel,...
(Filed With SEC on February 5, 2021)
-
Asset Purchase Agreement, dated as of January 5, 2021, by and between Rhythm Pharmaceuticals, Inc. and Alexion Pharmaceuticals, Inc
(Filed With SEC on January 5, 2021)
-
Form of Restricted Stock Unit Award Agreement
(Filed With SEC on March 2, 2020)
-
Underwriting Agreement dated October 15, 2019
(Filed With SEC on October 16, 2019)